Page last updated: 2024-08-17

1,2-dipalmitoylphosphatidylcholine and albuterol

1,2-dipalmitoylphosphatidylcholine has been researched along with albuterol in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Desai, TR; Finlay, WH; Hancock, RE1
Abo, M; Fujimura, M; Ishiura, Y; Kasahara, K; Kurashima, K; Nakao, S; Nobata, K1
Davies, MJ; Gibbons, P; Kerry, TD; Khoo, J; Murphy, MF; Naderi, M; Seton, L1

Other Studies

3 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and albuterol

ArticleYear
A facile method of delivery of liposomes by nebulization.
    Journal of controlled release : official journal of the Controlled Release Society, 2002, Nov-07, Volume: 84, Issue:1-2

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Adrenergic beta-Agonists; Aerosols; Albuterol; Amino Acid Sequence; Anti-Infective Agents; Chemical Phenomena; Chemistry, Physical; Ciprofloxacin; Dimyristoylphosphatidylcholine; Liposomes; Molecular Sequence Data; Particle Size; Phosphatidylcholines; Phosphatidylglycerols; Powders

2002
Inhaled lysophosphatidylcholine provokes bronchoconstriction in guinea pigs in vivo.
    European journal of pharmacology, 2005, Sep-27, Volume: 520, Issue:1-3

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Albuterol; Animals; Bronchial Hyperreactivity; Bronchoconstriction; Bronchoconstrictor Agents; Bronchodilator Agents; Guinea Pigs; Lysophosphatidylcholines; Male; Methacholine Chloride

2005
The crystal engineering of salbutamol sulphate via simulated pulmonary surfactant monolayers.
    International journal of pharmaceutics, 2013, Mar-25, Volume: 446, Issue:1-2

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Albuterol; Bronchodilator Agents; Chromatography, Gas; Crystallization; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Palmitic Acid; Phosphatidylglycerols; Pulmonary Surfactants; Surface-Active Agents; Technology, Pharmaceutical

2013